Ayrton Capital LLC - UNICYCIVE THERAPEUTICS INC ownership

UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 13 filers reported holding UNICYCIVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ayrton Capital LLC ownership history of UNICYCIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$45,000
-29.7%
76,6450.0%0.08%
-24.0%
Q2 2022$64,000
-35.4%
76,6450.0%0.10%
-19.4%
Q1 2022$99,000
-37.3%
76,6450.0%0.13%
-13.4%
Q4 2021$158,00076,6450.15%
Other shareholders
UNICYCIVE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Vivo Capital, LLC 3,470,152$2,984,3310.33%
Nantahala Capital Management 3,470,541$2,984,6660.26%
BVF INC/IL 3,413,563$2,935,6640.08%
RA Capital Management 3,470,688$2,984,7920.06%
TANDEM CAPITAL MANAGEMENT CORP /ADV 31,000$26,6600.01%
Virtu Financial LLC 10,994$90.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 52,399$45,0630.00%
STATE STREET CORP 35,036$30,1310.00%
GOLDMAN SACHS GROUP INC 93,233$80,1800.00%
View complete list of UNICYCIVE THERAPEUTICS INC shareholders